(Q37682560)

22 August 2017

1 reference

title

Managing highly insulin-resistant diabetes mellitus: weight loss approaches and medical management (English)

1 reference

22 August 2017

1 reference

1 reference

Aparna Brown

1

1 reference

22 August 2017

Megha Desai

series ordinal

2

1 reference

22 August 2017

Deepa Taneja

series ordinal

3

1 reference

22 August 2017

Lisa R Tannock

series ordinal

4

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

22 August 2017

published in

Postgraduate Medicine

1 reference

22 August 2017

volume

122

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

163-171

1 reference

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Obesity and disease management: effects of weight loss on comorbid conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Effect of degree of weight loss on health benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Comparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Long-term weight maintenance after an intensive weight-loss program

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Five-year self-management of weight using meal replacements: comparison with matched controls in rural Wisconsin

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients: impact on cardiovascular risk reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Stable behaviors associated with adults' 10-year change in body mass index and likelihood of gain at the waist

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Short-term exercise improves beta-cell function and insulin resistance in older people with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

One-year weight losses in the Look AHEAD study: factors associated with success

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

A Colorado statewide survey of walking and its relation to excessive weight

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Self-help weight loss versus a structured commercial program after 26 weeks: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Weight loss and long-term follow-up of severely obese individuals treated with an intense behavioral program

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Impact of different levels of weight loss on blood pressure in overweight and obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

A comparison of meal replacements and medication in weight maintenance after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

A dietary quality comparison of popular weight-loss plans

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

International trial of long-term dexfenfluramine in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Pharmacological therapies for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Low-dose orlistat effects on body weight of mildly to moderately overweight individuals: a 16 week, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Meta-analysis: pharmacologic treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Bariatric surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Adding pioglitazone to insulin containing regimens in type 2 diabetes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Use of thiazolidinediones and fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Inverse relation between amylin and glucagon secretion in healthy and diabetic human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

High-dose insulin therapy: is it time for U-500 insulin?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

The use of U-500 in patients with extreme insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2010.01.2110

21 January 2018

Identifiers

DOI

10.3810/PGM.2010.01.2110

1 reference

22 August 2017

1 reference